Phase 2 Clinical Trial for COVID-19 Antiviral Begins
RedHill Biopharma announced today it has begun its phase 2 clinical trial by enrolling its first participant in a smaller outpatient study. “Enrollment of the first patient in the study marks an important milestone for RHB-107 in the 300-patient U.S. …